Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli

At Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli, the strongest research activity is in neoplasms and hemic and lymphatic diseases, with many studies focused on common and hard-to-treat cancers such as non-small cell lung cancer, colorectal cancer, gastric cancer, and head and neck squamous cell carcinoma. These trials are designed to test new treatment options, compare them with current standards, and improve outcomes for patients with advanced or recurrent disease.

• Testing new cancer therapies for advanced solid tumors and metastatic disease
• Evaluating treatment effectiveness in lung, gastrointestinal, and head and neck cancers
• Studying personalized approaches for biomarker-selected tumors

The UOC Oncoematologia also participates in studies for blood cancers and related disorders, reflecting a broad oncology program with a strong translational focus.

A major part of the site’s portfolio covers immune system diseases and inflammatory conditions, including multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, and myasthenia gravis. These trials aim to better control disease activity, reduce relapses, and assess whether newer therapies can improve long-term management compared with established treatments.

• Exploring therapies for relapsing and progressive multiple sclerosis
• Assessing new options for lupus, rheumatoid arthritis, and juvenile arthritis
• Studying treatments that may improve symptoms in myasthenia gravis

Research in this area combines symptom control with the search for safer, more durable treatment strategies.

The site is active in digestive system diseases and liver-related research, with studies in Crohn's disease, ulcerative colitis, pouchitis, esophageal disorders, hepatocellular carcinoma, and biliary tract cancer. These trials are mainly aimed at improving disease control, supporting remission, and evaluating new treatment approaches for both inflammatory and malignant conditions of the gastrointestinal tract.

• Testing therapies for inflammatory bowel disease and chronic pouchitis
• Studying treatments for liver and biliary cancers
• Evaluating options for esophageal and gastric cancers

This area shows a strong mix of cancer research and chronic digestive disease management.

Clinical trials also address nervous system diseases, including Parkinson's disease, Alzheimer’s disease, amyotrophic lateral sclerosis, epilepsy, and Lewy body dementia. The main goal is to evaluate therapies that may slow progression, improve daily functioning, or ease symptoms in conditions with major long-term impact on patients and families.

• Investigating treatments for movement disorders and cognitive decline
• Studying therapies for ALS and refractory epilepsy
• Assessing new approaches for dementia-related symptoms

This research supports both symptom relief and disease-modifying strategies in complex neurological conditions.

Another important research theme includes skin and connective tissue diseases, musculoskeletal diseases, and related inflammatory disorders such as atopic dermatitis, psoriasis, hidradenitis suppurativa, prurigo nodularis, and psoriatic arthritis. Trials in this group are focused on reducing inflammation, improving skin symptoms, and helping patients achieve better day-to-day quality of life.

• Evaluating new treatments for chronic inflammatory skin diseases
• Studying therapies for psoriatic and rheumatologic conditions
• Testing approaches to improve long-term symptom control

The research portfolio here reflects a strong interest in immune-driven skin and joint disease.

The site also runs trials in nutritional and metabolic diseases, cardiovascular diseases, and kidney disease, including chronic kidney disease, immunoglobulin A nephropathy, type 2 diabetes, hypertension, and myocardial infarction. These studies are designed to slow disease progression, reduce complications, and evaluate whether new therapies can improve long-term health outcomes.

• Studying treatments to protect kidney function and delay progression
• Evaluating therapies for diabetes and high blood pressure
• Assessing cardiovascular risk reduction strategies

This area adds an important chronic disease dimension to the site’s broader clinical trial program.

A smaller but notable set of studies focuses on eye diseases and other rare disorders, including geographic atrophy, age-related macular degeneration, retinitis pigmentosa, and inherited syndromes such as neurofibromatosis type 1 and Turner syndrome. The purpose of these trials is to improve diagnosis, preserve function, and explore innovative treatments for conditions with limited options.

• Testing therapies for degenerative retinal disease
• Studying rare genetic and developmental disorders
• Exploring approaches that may preserve vision or function

These studies highlight the site’s involvement in specialized research beyond common adult diseases.